Restoring funding for basic biomedical research appears to have lost favor with policymakers, because it does not offer immediate self-sustaining economic returns. And funding for basic research remains a low priority in emerging economies like China, where it accounts for less than 15 cents for every research dollar spent (compared to 35 cents in the US).
恢复对基础生物医学研究的拨款似乎并不受决策者待见，因为这无法立刻产生能自我维持的经济回报。而在中国等新兴经济体，基础研究拨款的优先等级也很低，并且每1美元的研究投入只能产生15美分（美国是35美分）。